Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP297016.RAFI1Ezg2AVbkISR92Tj4LkLVcjfF9x4u82mQTcOBQ2Rk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP297016.RAFI1Ezg2AVbkISR92Tj4LkLVcjfF9x4u82mQTcOBQ2Rk130_assertion type Assertion NP297016.RAFI1Ezg2AVbkISR92Tj4LkLVcjfF9x4u82mQTcOBQ2Rk130_head.
- NP297016.RAFI1Ezg2AVbkISR92Tj4LkLVcjfF9x4u82mQTcOBQ2Rk130_assertion description "[Epidermal growth factor receptor (EGFR) transmembrane glycoprotein has been demonstrated to be overexpressed in pancreatic cancer, and it correlates with more advanced disease, poor survival, and the presence of metastases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP297016.RAFI1Ezg2AVbkISR92Tj4LkLVcjfF9x4u82mQTcOBQ2Rk130_provenance.
- NP297016.RAFI1Ezg2AVbkISR92Tj4LkLVcjfF9x4u82mQTcOBQ2Rk130_assertion evidence source_evidence_literature NP297016.RAFI1Ezg2AVbkISR92Tj4LkLVcjfF9x4u82mQTcOBQ2Rk130_provenance.
- NP297016.RAFI1Ezg2AVbkISR92Tj4LkLVcjfF9x4u82mQTcOBQ2Rk130_assertion SIO_000772 23560505 NP297016.RAFI1Ezg2AVbkISR92Tj4LkLVcjfF9x4u82mQTcOBQ2Rk130_provenance.
- NP297016.RAFI1Ezg2AVbkISR92Tj4LkLVcjfF9x4u82mQTcOBQ2Rk130_assertion wasDerivedFrom befree-20150227 NP297016.RAFI1Ezg2AVbkISR92Tj4LkLVcjfF9x4u82mQTcOBQ2Rk130_provenance.
- NP297016.RAFI1Ezg2AVbkISR92Tj4LkLVcjfF9x4u82mQTcOBQ2Rk130_assertion wasGeneratedBy ECO_0000203 NP297016.RAFI1Ezg2AVbkISR92Tj4LkLVcjfF9x4u82mQTcOBQ2Rk130_provenance.